Literature DB >> 21473630

Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells.

Supang Khondee1, Abdulgader Baoum, Teruna J Siahaan, Cory Berkland.   

Abstract

Targeted gene delivery using nonviral vectors is a highly touted scheme to reduce the potential for toxic or immunological side effects by reducing dose. In previous reports, TAT polyplexes with DNA have shown relatively poor gene delivery. The transfection efficiency has been enhanced by condensing TAT/DNA complexes to a small particle size using calcium. To explore the targetability of these condensed TAT complexes, LABL peptide targeting intercellular cell-adhesion molecule-1 (ICAM-1) was conjugated to TAT peptide using a polyethylene glycol (PEG) spacer. PEGylation reduced the transfection efficiency of TAT, but TAT complexes targeting ICAM-1 expressing cells regained much of the lost transfection efficiency. Targeted block peptides properly formulated with calcium offer promise for gene delivery to ICAM-1 expressing cells at sites of injury or inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21473630      PMCID: PMC4207658          DOI: 10.1021/mp100393j

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  63 in total

Review 1.  Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.

Authors:  Jehangir S Wadia; Steven F Dowdy
Journal:  Adv Drug Deliv Rev       Date:  2004-12-19       Impact factor: 15.470

2.  Macro-branched cell-penetrating peptide design for gene delivery.

Authors:  Zhihui Liu; Moyi Li; Dafu Cui; Jian Fei
Journal:  J Control Release       Date:  2005-02-16       Impact factor: 9.776

3.  Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus.

Authors:  Jesus M de la Fuente; Catherine C Berry
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

4.  Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides.

Authors:  Takehiko Shiraishi; Stanislava Pankratova; Peter E Nielsen
Journal:  Chem Biol       Date:  2005-08

Review 5.  Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.

Authors:  S-D Li; L Huang
Journal:  Gene Ther       Date:  2006-09       Impact factor: 5.250

6.  A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy.

Authors:  S Moein Moghimi; Peter Symonds; J Clifford Murray; A Christy Hunter; Grazyna Debska; Adam Szewczyk
Journal:  Mol Ther       Date:  2005-06       Impact factor: 11.454

Review 7.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

8.  An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

Authors:  A A Beg; D Baltimore
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

9.  Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx.

Authors:  Gregory E R Weller; Flordeliza S Villanueva; Eric M Tom; William R Wagner
Journal:  Biotechnol Bioeng       Date:  2005-12-20       Impact factor: 4.530

Review 10.  Cell and tissue targeting of nucleic acids for cancer gene therapy.

Authors:  Verena Russ; Ernst Wagner
Journal:  Pharm Res       Date:  2007-03-27       Impact factor: 4.580

View more
  17 in total

Review 1.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

2.  Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice.

Authors:  Susumu Ishiguro; Nabil A Alhakamy; Deepthi Uppalapati; Jennifer Delzeit; Cory J Berkland; Masaaki Tamura
Journal:  J Pharm Sci       Date:  2016-10-18       Impact factor: 3.534

Review 3.  Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases.

Authors:  Mario E G Moral; Teruna J Siahaan
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

Review 4.  Physical non-viral gene delivery methods for tissue engineering.

Authors:  Adam J Mellott; M Laird Forrest; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2012-10-26       Impact factor: 3.934

5.  Effect of lipid headgroup charge and pH on the stability and membrane insertion potential of calcium condensed gene complexes.

Authors:  Nabil A Alhakamy; Ibrahim Elandaloussi; Saba Ghazvini; Cory J Berkland; Prajnaparamita Dhar
Journal:  Langmuir       Date:  2015-03-30       Impact factor: 3.882

6.  Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes.

Authors:  Nabil A Alhakamy; Cory J Berkland
Journal:  Mol Pharm       Date:  2013-04-15       Impact factor: 4.939

7.  Cell membrane-formed nanovesicles for disease-targeted delivery.

Authors:  Jin Gao; Dafeng Chu; Zhenjia Wang
Journal:  J Control Release       Date:  2016-01-14       Impact factor: 9.776

Review 8.  Noncovalently associated cell-penetrating peptides for gene delivery applications.

Authors:  Nabil A Alhakamy; Adane S Nigatu; Cory J Berkland; Joshua D Ramsey
Journal:  Ther Deliv       Date:  2013-06

9.  AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray.

Authors:  Nabil A Alhakamy; Susumu Ishiguro; Deepthi Uppalapati; Cory J Berkland; Masaaki Tamura
Journal:  Mol Cancer Ther       Date:  2015-12-04       Impact factor: 6.261

Review 10.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.